Asset
PEMBROLIZUMAB
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02178722 | phase1_2 | completed | 2014-07-17 | 2018-11-26 | Incyte Corporation | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers |
FDA applications (0)
This company has no applications containing this asset.